Genes Related to Suppression of Malignant Phenotype Induced by Maitake D-Fraction in Breast Cancer Cells

• Published in: Journal of medicinal food Vol. 16; no. 7; pp. 602 - 617
• Main Authors: Alonso, Eliana Noelia, Orozco, Manuela, Nieto, Alvaro Eloy, Balogh, Gabriela Andrea
• Format: Journal Article
• Language: English
• Published: United States Mary Ann Liebert, Inc 01.07.2013
• Subjects: antineoplastic activity; apoptosis; Apoptosis - drug effects; breast neoplasms; Breast Neoplasms - genetics; Breast Neoplasms - metabolism; Breast Neoplasms - pathology; Cell Cycle - drug effects; cell cycle checkpoints; cell growth; Cell Proliferation - drug effects; chemoprevention; complementary DNA; dose response; Female; gene expression; Gene Expression Regulation, Neoplastic - drug effects; genes; Grifola - chemistry; Humans; macrophages; MCF-7 Cells; metastasis; microarray technology; mushrooms; natural killer cells; neoplasm cells; Phenotype; polysaccharides; Polysaccharides - pharmacology; RNA; T-lymphocytes; United States
• ISSN: 1557-7600; 1557-7600
• DOI: 10.1089/jmf.2012.0222

It is already known that the Maitake (D-Fraction) mushroom is involved in stimulating the immune system and activating certain cells that attack cancer, including macrophages, T-cells, and natural killer cells. According to the U.S. National Cancer Institute, polysaccharide complexes present in Maitake mushrooms appear to have significant anticancer activity. However, the exact molecular mechanism of the Maitake antitumoral effect is still unclear. Previously, we have reported that Maitake (D-Fraction) induces apoptosis in breast cancer cells by activation of BCL2-antagonist/killer 1 (BAK1) gene expression. At the present work, we are identifying which genes are responsible for the suppression of the tumoral phenotype mechanism induced by Maitake (D-Fraction) in breast cancer cells. Human breast cancer MCF-7 cells were treated with and without increased concentrations of Maitake D-Fraction (36, 91, 183, 367 μg/mL) for 24 h. Total RNA were isolated and cDNA microarrays were hybridized containing 25,000 human genes. Employing the cDNA microarray analysis, we found that Maitake D-Fraction modified the expression of 4068 genes (2420 were upmodulated and 1648 were downmodulated) in MCF-7 breast cancer cells in a dose-dependent manner during 24 h of treatment. The present data shows that Maitake D-Fraction suppresses the breast tumoral phenotype through a putative molecular mechanism modifying the expression of certain genes (such as IGFBP-7, ITGA2, ICAM3, SOD2, CAV-1, Cul-3, NRF2, Cycline E, ST7, and SPARC) that are involved in apoptosis stimulation, inhibition of cell growth and proliferation, cell cycle arrest, blocking migration and metastasis of tumoral cells, and inducing multidrug sensitivity. Altogether, these results suggest that Maitake D-Fraction could be a potential new target for breast cancer chemoprevention and treatment.